Anti-arthritic preparation
Patent 4743596 Issued on May 10, 1988. Estimated Expiration Date: 
June 16, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 16, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAntiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment Composition Patent #: 4232012 InventorApplicationNo. 07/062626 filed on 06/16/1987US Classes:514/161, With heterocyclic compound514/177, Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system514/407Chalcogen or nitrogen bonded directly to the pyrazole ring by nonionic bondingExaminersPrimary: Friedman, Stanley J.International ClassA61K 31/60 (20060101)AbstractAn anti-arthritic preparation consisting essentially of the anti-inflammatory, nonsteroidal agents aspirin and phenylbutazone, the anti-inflammatory corticosteroid prednisone, and the skeletal muscle relaxant methocarbamol. The use of calcium carbonate and vitamin D as adjuncts is contemplated in protecting against osteoporosis and possible replacement of bone tissue.Field of SearchWith heterocyclic compound | |
